3,4-dihydroxyphenylacetic acid has been researched along with fk 409 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Delogu, MR; Desole, MS; Esposito, G; Miele, E; Miele, M; Migheli, R; Mura, MP; Rocchitta, G; Serra, PA; Taras, MG | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and fk 409
Article | Year |
---|---|
Role of the nitric oxide/cyclic GMP pathway and extracellular environment in the nitric oxide donor-induced increase in dopamine secretion from PC12 cells: a microdialysis in vitro study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Ascorbic Acid; Calcium; Calcium Channel Blockers; Cell Survival; Cyclic GMP; Dopamine; Enzyme Inhibitors; Extracellular Space; Homovanillic Acid; Microdialysis; Nitric Oxide; Nitric Oxide Donors; Nitro Compounds; PC12 Cells; Pheochromocytoma; Potassium; Rats; S-Nitroso-N-Acetylpenicillamine | 2003 |